Abstract:Background:The majority of patients with colorectal cancer (CRC) have increased levels of soluble cancer-associated biomarkers at diagnosis of primary disease.Subjects with clean colorectum at colonoscopy may however, also have increased levels of such biomarkers.The aim of the present study was to evaluate a possible association between increased levels of soluble TIMP-1, CEA, CA19-9 and YKL-40 in subjects offered colorectal endoscopy without findings of neoplastic bowel lesions and subsequent long-term risk of developing a primary malignant disease.Methods: During 2004/05 4,509 subjects were included in a multicenter study with collection of blood samples before sigmoido-and/or colonoscopy due to symptoms of CRC.The aim was to evaluate a possible relation between certain biomarkers and subsequent findings at endoscopy.A subgroup of 1,025 subjects had findings of diverticula and was chosen as research group, because the median age was similar to the subjects diagnosed with colorectal neoplasia.The levels of TIMP-1, CEA and CA19-9 were determined in EDTA plasma at an automatic analysis platform "Architect®" at Abbotts Center of Excellence, Amsterdam and YKL-40 was determined on a validated commercially available ELISA platform (Quidell, USA) at Herlev Hospital.With cut-point 12.31.2012 the subjects, who have developed a primary malignant disease, except skin cancer, were identified and a relation between the biomarker levels at endoscopy and long-term risk of developing malignancy was calculated.On the basis of calculated normal levels, the relation with the biomarkers was separated into three groups: 0 = none of the four increased; 1 = one of the four increased; 2 = two or more of the four increased.In addition, the time from endoscopy to development of malignancy within the first five years was included; the model also includes an analysis of competing risk of dead before development of malignancy.Results: In total, 152 of the 1,025 subjects with diverticula developed a primary malignant disease within the observation period.Univariate analyses of the biomarker levels in the three predefined groups showed that TIMP-1 (p=0.0004),CEA (p=0.009) and CA19-9 (p=0.028) were significantly associated with development of malignancy.In a subsequent multivariate analysis including the three biomarkers showed that increased levels were associated with development of subsequent malignancy (p=0.0014).The cumulated risk of developing a primary malignant disease within the first five years was: group 0: 0.075 (0.055-0.099); group 1: 0.088 (0.059-0.126); group 2: 0.167 (0.120-0.221).Conclusion: Increased levels of the soluble biomarkers plasma TIMP-1, CEA and CA19-9 at endoscopy with findings of diverticula are associated with subsequent risk of developing a primary malignant disease.

Higher Plasma Concentration of TP53-induced Glycolysis and Apoptosis Regulator is Associated with a Lower Risk of Colorectal Cancer Metastasis

Immune landscape of hepatocellular carcinoma: The central role of TP53-inducible glycolysis and apoptosis regulator

ANGPTL1 Attenuates Colorectal Cancer Metastasis by Up-Regulating Microrna-138

Identification of the TP53-induced glycolysis and apoptosis regulator in various stages of colorectal cancer patients

Characterization of the Fatty Acid Metabolism in Colorectal Cancer to Guide Clinical Therapy

TIGAR is correlated with maximal standardized uptake value on FDG-PET and survival in non-small cell lung cancer.

Expression of TIGIT/CD155 and Correlations with Clinical Pathological Features in Human Hepatocellular Carcinoma

The Impact of TP53-Induced Glycolysis and Apoptosis Regulator on Prognosis in Hepatocellular Carcinoma: Association with Tumor Microenvironment and Ferroptosis

Identify Urinary Biomarkers For Colorectal Carcinoma Liver Metastasis

872 Mir-650: A Potential Prognostic Biomarker and Therapeutic Target in Non-Metastasis Colorectal Carcinoma

The Role of TMIGD1 As a Tumor Suppressor in Colorectal Cancer

Tumor-Infiltrating Immune Cells Act as a Marker for Prognosis in Colorectal Cancer

TIGAR Enhanced Free Ca2+ Concentration in Hepatocellular Carcinoma Cells to Accelerate the Sustained Proliferation and Drug Resistance

A comprehensive analysis of TRP-related gene signature, and immune infiltration in patients with colorectal cancer

Gamma‐glutamyl Transpeptidase Level is a Novel Adverse Prognostic Indicator in Human Metastatic Colorectal Cancer

Lipid levels and insulin resistance markers in patients with colorectal cancer: Propensity score matching analysis

Cancer/testis antigens and clinical risk factors for liver metastasis of colorectal cancer: a predictive panel.

ITGAE Defines CD8+ Tumor-Infiltrating Lymphocytes Predicting a Better Prognostic Survival in Colorectal Cancer

TIGAR drives colorectal cancer ferroptosis resistance through ROS/AMPK/SCD1 pathway

Comprehensively prognostic and immunological analyses of GLP-1 signaling-related genes in pan-cancer and validation in colorectal cancer

TP53-inducible Glycolysis and Apoptosis Regulator (TIGAR) Metabolically Reprograms Carcinoma and Stromal Cells in Breast Cancer